Parent Project Muscular Dystrophy / CURRENT AND FUTURE DIAGNOSIS AND MANAGEMENT / EFPIA / /
Continent
America / Europe / /
Country
Canada / /
Currency
EUR / / /
Facility
Patient-Centered Outcomes Research Institute / / /
IndustryTerm
web references / patient advocacy / pharmaceutical development / http /
MedicalCondition
Duchenne’s Disease / HIV / DIABETIC KIDNEY DISEASE BIOMARKERS / Multiple Sclerosis / metabolic disorders / illness / ROLE OF AMYLOID BIOMARKERS IN THE CURRENT AND FUTURE DIAGNOSIS AND MANAGEMENT OF PATIENTS ACROSS THE SPECTRUM OF COGNITIVE IMPAIRMENT / specific diseases / disease / patient advocacy group Parent Project Muscular Dystrophy / diabetes / diseases / neurodegenerative diseases / Duchene Muscular Dystrophy / FROM PRE-DEMENTIA TO DEMENTIA / MODELS OF PATIENT ENGAGEMENT AND ACCESS FOR EARLIER IDENTIFICATION OF ALZHEIMER’S DISEASE / /
Organization
Patient Task Force / European Patients Academy on Therapeutic Innovation / Committee for Medicinal Products for Human Use / World Health Organisation / European Medicines Agency / Pharmaceutical Industries Association / Patient-Centered Outcomes Research Institute / FDA Centre for Devices and Radiological Health / FDA / Biotechnology Industry Organization / European Federation / European Union / FDA Centre for Drug / IMI Governing Board / / /
Position
representative of a wider group / physician / forward for testing via case studies / representative / Private / /
Product
Patient-Focused Drug / /
RadioStation
4 What / /
Technology
Biotechnology / medical information technology / drug development / /
Document version 1 Last update: Reference Number : IMI2/INTTel + • Fax + • www.imi.europa.eu